We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

By HospiMedica International staff writers
Posted on 15 Mar 2024
Print article
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons to quickly identify any bleeding to prevent minor bleeds from turning into serious complications. Now, a novel monitoring device offers real-time detection of bleeding during endovascular procedures, ensuring better outcomes and providing peace of mind for patients at high risk of bleeding.

The Early Bird Bleed Monitoring System (EBBMS) from Saranas, Inc. (Houston, TX, USA) is the only FDA-approved system for real-time bleed monitoring, marking a significant step forward in reducing healthcare expenses and enhancing patient care during endovascular procedures. The system employs the Bleed Detection Array to generate bioimpedance signals that track bleeding status, with simple indicators alerting surgeons to potential bleeds and signaling when intervention is necessary. Both animal studies and clinical trials have consistently shown a direct correlation between reduced bioimpedance levels and increased bleed volume. Early Bird can identify bleed progression with a statistically significant increase in volume detected at each bleed indicator level.

The "SAFE-MCS" study, a multi-center U.S. clinical trial, has assessed the safety of performing complex, high-risk percutaneous coronary interventions (PCI) with mechanical circulatory support (MCS) and monitoring with EBBMS. PCI is a non-surgical method for treating coronary artery blockages and restoring blood flow to the heart. This study, involving 203 patients from various U.S. centers, showcased EBBMS's capability to identify and mitigate bleeding complications during protected PCI. Protected PCI, which uses MCS to temporarily support the heart's pumping action, is a recognized treatment method. This pioneering study focused on bleeding complications during protected PCI, highlighting a significant decline in such complications among patients monitored with EBBMS.


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
24.5-inch Full HD 2D OLED Medical Monitor

Print article


Critical Care

view channel
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)

New Device Treats Acute Kidney Injury from Sepsis

Sepsis, commonly referred to as "blood poisoning," can occur due to any infectious agent, triggering a systemic response by the body to combat the infection. This response involves the activation of circulating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.